ELUT

Elutia Inc.

ELUT.US elutia.com + Research + Basket
CIK 0001708527
Employees 25
Phone 240 247 1170
Fiscal year end December
IPO Sep 07, 2023
Address 20 Firstfield Road, Gaithersburg, MD, United States, 20878
0.76
-0.05 (-6.59%)
USD · NASDAQ
52-week range
0.50
1.39
Trading at 29% of the 52-week range
Market Cap
36.02M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.36
Div. Yield
N/A
% Institutions
43.62%
% Insiders
3.58%

1 Year

-17.4%

3 Year

-45.0%

10 Year

-94.8%
Description

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.

Actions

Add an action for ELUT.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. C. Randal Mills Ph.D. Co-Founder, President, CEO & Director 1972
Mr. Matthew B. Ferguson Chief Financial Officer 1968
Dr. Michelle LeRoux Williams Ph.D. Chief Scientific Officer 1975
Ms. Tamara Grossett Head of People NA
Dr. Sonali Fonseca Ph.D. VP & Head of Emerging Businesses NA
Mr. Dwayne Montgomery Head of Cardiovascular 1968
Mr. Peter J. Ligotti Chief Commercial Officer NA
Mr. Jeffry D. Hamet Senior VP of Finance, Treasurer & Secretary NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jan 30, 2026 Guido J Neels N/A Purchase 20.00K $1.04 $20.80K SEC
Jan 30, 2026 Kevin Rakin N/A Purchase 70.00K $1.06 $74.20K SEC
Jan 28, 2026 Guido J Neels N/A Purchase 15.00K $1.06 $15.90K SEC
Dec 17, 2025 Brigid Makes N/A Purchase 25.00K $0.52 $13.00K SEC
Dec 17, 2025 C Randal Mills N/A Purchase 3.00K $0.51 $1.53K SEC
Dec 17, 2025 David Colpman N/A Purchase 12.50K $0.51 $6.38K SEC
Dec 17, 2025 Kevin Rakin N/A Purchase 50.00K $0.52 $26.00K SEC
Dec 17, 2025 Matthew Ferguson N/A Purchase 60.00K $0.53 $31.80K SEC
Dec 02, 2025 Matthew Ferguson N/A Purchase 5.50K $0.67 $3.69K SEC
Dec 01, 2025 Matthew Ferguson N/A Purchase 4.50K $0.65 $2.93K SEC
Nov 24, 2025 C Randal Mills N/A Purchase 5.00K $0.60 $3.00K SEC
Nov 17, 2025 David Colpman N/A Purchase 15.50K $0.74 $11.47K SEC
Nov 13, 2025 C Randal Mills N/A Purchase 13.50K $0.75 $10.13K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Nantahala Capital Management, LLC 6.37M Jun 30, 2026 14.38% $0.10 100.00%
AIGH Capital Management, LLC 2.70M Jun 30, 2026 6.09% $0.17 -25.02%
Knollwood Investment Advisory LLC 2.56M Jun 30, 2026 5.77% $0.22 0.00%
SILVERARC CAPITAL MANAGEMENT, LLC 2.19M Jun 30, 2026 4.95% $0.22 -12.21%
Vanguard Capital Management, LLC 1.14M Jun 30, 2026 2.58% $0.00 11.61%
Perkins Capital Management Inc 694.09K Jun 30, 2026 1.57% $0.29 -8.30%
Geode Capital Management, LLC 285.23K Jun 30, 2026 0.64% $0.00 -2.78%
CI Private Wealth LLC 253.50K Jun 30, 2026 0.57% $0.00 1.79%
Renaissance Technologies Corp 201.82K Jun 30, 2026 0.46% $0.00 143.99%
Vanguard Fiduciary Trust Co 172.45K Jun 30, 2026 0.39% $0.00 44.49%
BlackRock Inc 167.86K Jun 30, 2026 0.38% $0.00 37.51%
Birchview Capital, LP 165.09K Jun 30, 2026 0.37% $0.08 0.00%
Citadel Advisors Llc 123.51K Jun 30, 2026 0.28% $0.00 10.17%
Rossmore Private Capital 120.00K Jun 30, 2026 0.27% $0.01 0.00%
GSA Capital Partners LLP 89.39K Jun 30, 2026 0.20% $0.01 0.00%
XTX Topco Ltd 52.61K Jun 30, 2026 0.12% $0.00 37.89%
Jane Street Group LLC 44.70K Jun 30, 2026 0.10% $0.00 -30.24%
Northern Trust Corp 44.67K Jun 30, 2026 0.10% $0.00 61.49%
Atom Investors LP 44.23K Jun 30, 2026 0.10% $0.00 0.00%
LRI Investments, LLC 25.22K Jun 30, 2026 0.06% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 899.93K 2.03% ▲ 0.00% Sep 30, 2026
2 Fidelity Extended Market Index 139.26K 0.31% ▼ 0.53% Aug 31, 2026
3 iShares Micro-Cap ETF 106.33K 0.24% ▲ 0.00% Oct 29, 2026
4 Fidelity Total Market Index 44.70K 0.10% ▲ 0.00% Aug 31, 2026
5 Perkins Discovery 37.50K 0.08% ▲ 0.00% Mar 31, 2026
6 Fidelity Series Total Market Index 36.71K 0.08% ▲ 0.00% Aug 31, 2026
7 Fidelity Nasdaq Composite Index 9.30K 0.02% ▲ 0.00% Aug 31, 2026
8 Vanguard U.S. Eq Idx £ Acc 8.14K 0.02% ▲ 0.00% Sep 30, 2026
9 1290 VT Micro Cap K 7.58K 0.02% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $36.02M
EBITDA: $-21.35M
Book Value: $0.36
Earnings/Share: $-0.67
Profit Margin: 426.90%
Operating Margin: -243.10%
ROA (TTM): -34.66%
ROE (TTM): 0.00%
Revenue (TTM): $12.14M
Revenue/Share (TTM): $0.28
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -11.60%

Valuation Metrics

Enterprise Value: $20.82M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 44.29M
Shares Float: 29.48M
% Insiders: 3.58%
% Institutions: 43.62%
Shares Short: 15.33K
Shares Short (Prior Month): 9.36K
Short Ratio: 0.04
Short % Float: 0.04%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$12.29M
Cost of Goods Sold
adjust
$-5.70M
Gross Profit
subtotal
$6.60M
SG&A
adjust
$-15.08M
R&D
adjust
$-4.16M
Other Operating Expense
adjust
$-5.77M
Operating Income
subtotal
$-18.41M
Other / Non-Operating Items
adjust
$71.79M
Net Income
subtotal
$53.38M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ELUT.US!